| Targeting oncogenic Notch signaling with SERCA inhibitors L Pagliaro, M Marchesini, G Roti Journal of Hematology & Oncology 14, 1-17, 2021 | 44 | 2021 |
| Blockade of oncogenic NOTCH1 with the SERCA inhibitor CAD204520 in T cell acute lymphoblastic leukemia M Marchesini, A Gherli, A Montanaro, L Patrizi, C Sorrentino, L Pagliaro, ... Cell chemical biology 27 (6), 678-697. e13, 2020 | 32 | 2020 |
| The-2518 A/G polymorphism of the monocyte chemoattractant protein-1 as a candidate genetic predisposition factor for secondary myelofibrosis and biomarker of disease severity E Masselli, C Carubbi, B Cambò, G Pozzi, G Gobbi, P Mirandola, E Follini, ... Leukemia 32 (10), 2266-2270, 2018 | 19 | 2018 |
| Targeting Notch trafficking and processing in cancers L Pagliaro, C Sorrentino, G Roti Cells 9 (10), 2212, 2020 | 16 | 2020 |
| Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia A Montanaro, S Kitara, E Cerretani, M Marchesini, C Rompietti, L Pagliaro, ... Cell Death & Disease 13 (6), 551, 2022 | 9 | 2022 |
| Acute lymphoblastic leukaemia L Pagliaro, SJ Chen, D Herranz, C Mecucci, CJ Harrison, CG Mullighan, ... Nature Reviews Disease Primers 10 (1), 41, 2024 | 3 | 2024 |
| Modern treatment approaches to adult acute T-lymphoblastic and myeloid/T-lymphoblastic leukemia: From current standards to precision medicine M Leoncin, R La Starza, G Roti, L Pagliaro, R Bassan, C Mecucci Current Opinion in Oncology 34 (6), 738-747, 2022 | 2 | 2022 |
| CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders L Pagliaro, E Cerretani, F Vento, A Montanaro, L Moron Dalla Tor, ... International Journal of Molecular Sciences 25 (2), 766, 2024 | 1 | 2024 |
| P336: a chemotranscriptomic screening identifies the reversal of glucocorticoid resistance in notch1 mutated T-ALL L Pagliaro, LM Dalla Tor, V Federica, P Andrei, L Monica, S Kleissle, ... HemaSphere 6, 236-237, 2022 | 1 | 2022 |
| Discovery of a new 1-(phenylsulfonyl)-1H-indole derivative targeting the EphA2 receptor with antiproliferative activity on U251 glioblastoma cell line L Guidetti, R Castelli, A Zappia, FR Ferrari, C Giorgio, E Barocelli, ... European Journal of Medicinal Chemistry 276, 116681, 2024 | | 2024 |
| Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML M Marchesini, A Gherli, E Simoncini, LMD Tor, A Montanaro, N Thongon, ... Nature Communications 15 (1), 4739, 2024 | | 2024 |
| Morphological, clinical, and molecular profiling of post-polycythemia vera accelerated/blast phase occurring with and without antecedent secondary myelofibrosis L Pelagatti, G Pozzi, S Cortellazzi, C Mancini, E Martella, L Pagliaro, ... Frontiers in Hematology 3, 1356561, 2024 | | 2024 |
| Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T‐cell lymphoblastic leukemia A Almeida, S T'Sas, L Pagliaro, I Fijalkowski, W Sleeckx, ... HemaSphere 8 (3), e51, 2024 | | 2024 |
| The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia A Montanaro, A D'Antuono, LM Dalla Tor, P Andrei, F Cavazzini, ... Blood 142, 118, 2023 | | 2023 |
| S239: SOX11 DRIVES B1A LINEAGE COMMITMENT AND B1A/MCL-LIKE LYMPHOMA FORMATION IN MICE T Pieters, L Pagliaro, P Ntziachristos, P Van Vlierberghe, S Goossens HemaSphere 7 (S3), e255698f, 2023 | | 2023 |
| Targeting Oncogenic NOTCH1 in T-cell Acute Lymphoblastic Leukemia With a Selective SERCA Inhibitor CAD204520 L Pagliaro Università degli studi di Parma. Dipartimento di Medicina e chirurgia, 2023 | | 2023 |
| Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia A Montanaro, A D'Antuono, L Moron Dalla Tor, P Andrei, A Ciringione, ... Blood 140 (Supplement 1), 3130-3131, 2022 | | 2022 |
| Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML M Marchesini, A Gherli, E Simoncini, A Montanaro, N Thongon, L Pagliaro, ... Blood 140 (Supplement 1), 673-674, 2022 | | 2022 |
| SERCA MODULATION COUNTERACTS GLUCOCORTICOID RESISTANCE IN T-ALL L Pagliaro, L Dalla Tor, L Monica, P Andrei, F Vento, E Simoncini, ... HAEMATOLOGICA 107, 19-19, 2022 | | 2022 |
| Poster: ALL-043: Selective Blockade of Oncogenic NOTCH1 with the New SERCA Inhibitor CAD204520 in T-cell Acute Lymphoblastic Leukemia M Marchesini, A Gherli, AML Winter, S Kitara, A Montanaro, L Pagliaro, ... Clinical Lymphoma Myeloma and Leukemia 21, S205, 2021 | | 2021 |
Matteo MarchesiniUniversity of Parma在 unipr.it 的电子邮件经过验证
Matteo MarchesiniUniversity of Parma在 unipr.it 的电子邮件经过验证